TARANTINI, GIUSEPPE
 Distribuzione geografica
Continente #
NA - Nord America 29.476
AS - Asia 5.808
EU - Europa 5.263
SA - Sud America 283
AF - Africa 107
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 11
Totale 40.964
Nazione #
US - Stati Uniti d'America 29.421
SG - Singapore 2.932
CN - Cina 1.928
IT - Italia 1.552
FI - Finlandia 719
DE - Germania 676
SE - Svezia 571
HK - Hong Kong 420
GB - Regno Unito 405
FR - Francia 381
RU - Federazione Russa 362
BR - Brasile 247
UA - Ucraina 223
VN - Vietnam 206
IN - India 167
NL - Olanda 111
IE - Irlanda 83
CI - Costa d'Avorio 64
AT - Austria 56
CA - Canada 46
EG - Egitto 22
GR - Grecia 21
TR - Turchia 21
PL - Polonia 19
BE - Belgio 16
AR - Argentina 12
AU - Australia 12
IQ - Iraq 12
JP - Giappone 12
CH - Svizzera 11
IR - Iran 11
MA - Marocco 11
EU - Europa 10
PK - Pakistan 9
UZ - Uzbekistan 9
BD - Bangladesh 8
PE - Perù 8
TW - Taiwan 8
ES - Italia 7
LK - Sri Lanka 7
TH - Thailandia 7
EC - Ecuador 6
HU - Ungheria 6
KR - Corea 6
MX - Messico 6
PH - Filippine 6
KZ - Kazakistan 5
LT - Lituania 5
MY - Malesia 5
PT - Portogallo 5
ZA - Sudafrica 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
CO - Colombia 4
DK - Danimarca 4
GE - Georgia 4
NZ - Nuova Zelanda 4
BG - Bulgaria 3
BY - Bielorussia 3
CZ - Repubblica Ceca 3
ID - Indonesia 3
IL - Israele 3
LB - Libano 3
RO - Romania 3
BO - Bolivia 2
EE - Estonia 2
KG - Kirghizistan 2
LV - Lettonia 2
MT - Malta 2
NP - Nepal 2
PA - Panama 2
SA - Arabia Saudita 2
SI - Slovenia 2
AM - Armenia 1
CL - Cile 1
CM - Camerun 1
CR - Costa Rica 1
CY - Cipro 1
DZ - Algeria 1
GA - Gabon 1
HR - Croazia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
LY - Libia 1
MD - Moldavia 1
MK - Macedonia 1
MN - Mongolia 1
NO - Norvegia 1
PS - Palestinian Territory 1
PY - Paraguay 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
UY - Uruguay 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 40.964
Città #
Fairfield 4.656
Woodbridge 2.524
Chandler 2.511
Houston 2.053
Ashburn 2.010
Cambridge 1.663
Seattle 1.635
Wilmington 1.551
Ann Arbor 1.471
Singapore 1.409
Santa Clara 942
Jacksonville 910
Boardman 888
Princeton 656
San Diego 601
Beijing 503
Medford 478
Hong Kong 415
Roxbury 376
Helsinki 366
Padova 353
Des Moines 331
Nanjing 281
Dong Ket 196
London 107
Milan 102
New York 90
Ogden 80
Dublin 76
Guangzhou 76
Nanchang 71
Shenyang 68
Abidjan 64
Hebei 63
Rome 60
Norwalk 57
Nuremberg 51
Falkenstein 43
Changsha 42
Jiaxing 40
Falls Church 38
Los Angeles 37
Jinan 36
Tianjin 36
Hefei 31
Lappeenranta 31
São Paulo 27
Kharkiv 26
Redwood City 26
Shanghai 25
Vienna 23
Washington 23
Toronto 21
Munich 20
Naples 20
Kilburn 19
Ningbo 18
Palermo 18
Zhengzhou 18
Genoa 17
Indiana 17
Kunming 17
Paris 17
Florence 16
Frankfurt am Main 15
Taizhou 15
Bologna 14
Borås 14
Dearborn 14
Rockville 14
Amsterdam 13
Chicago 13
Hangzhou 13
Mahbubnagar 13
New Bedfont 13
Berlin 12
Haikou 12
Hounslow 12
Moscow 12
Mumbai 12
Tappahannock 12
Dallas 11
Las Vegas 11
Treviso 11
Chiswick 10
Lauterbourg 10
Rheinfelden 10
Verona 10
Villafranca Padovana 10
Prescot 9
Rio de Janeiro 9
Tashkent 9
Turin 9
Vicenza 9
Acton 8
Bari 8
Carol Stream 8
Colombo 8
Istanbul 8
Ottawa 8
Totale 30.845
Nome #
2017 ESC/EACTS Guidelines for the management of valvular heart disease 185
Apicobasal gradient of left ventricular myocardial edema underlies transient T-wave inversion and QT interval prolongation (Wellens’ ECG pattern) in Tako-Tsubo cardiomyopathy 162
Acute decompensated heart failure in young woman with lymphoproliferative disorder 150
Unravelling the (arte)fact of increased pacemaker rate with the Edwards SAPIEN 3 valve 148
Right Ventricular Junctional Late Gadolinium Enhancement Correlates With Outcomes in Pulmonary Hypertension 137
Three-dimensional electroanatomical voltage mapping and histologic evaluation of myocardial substrate in right ventricular outflow tract tachycardia. 136
Postconditioning during coronary angioplasty in acute myocardial infarction: the POST-AMI trial. 136
Acute procedural and six-month clinical outcome in patients treated with a dedicated bifurcation stent for left main stem disease: the TRYTON LM multicentre registry. 133
Imaging Study of Ventricular Scar in Arrhythmogenic Right Ventricular Cardiomyopathy: Comparison of 3D Standard Electroanatomical Voltage Mapping and Contrast-Enhanced Cardiac Magnetic Resonance. 130
The rise of new technologies for aortic valve stenosis: A comparison of sutureless and transcatheter aortic valve implantation 130
Sex Differences in Revascularization, Treatment Goals, and Outcomes of Patients With Chronic Coronary Disease: Insights From the ISCHEMIA Trial 129
Impact of preoperative mitral valve regurgitation on outcomes after transcatheter aortic valve implantation. 129
Cardiac arrest due to acute massive aortic root thrombosis after pericardial bioprosthetic aortic valve replacement 128
Coronary microvascular dysfunction correlates with the new onset of cardiac allograft vasculopathy in heart transplant patients with normal coronary angiography. 126
Impact of type of intervention for aortic valve replacement on heart rate variability 126
Incidence, Predictors, and Outcome of Conduction Disorders After Transcatheter Self-Expandable Aortic Valve Implantation. 125
Design and methodologies of the POSTconditioning during coronary angioplasty in acute myocardial infarction (POST-AMI) trial. 124
Anatomical Predictors of Pacemaker Dependency after Transcatheter Aortic Valve Replacement 124
Coronary vasospasm complicated by ventricular fibrillation: arrhythmogenic morphological substrates detected in vivo by cardiac magnetic resonance. 123
A2-P3 oblique clipping for the treatment of severe mitral regurgitation in the presence of mitral valve cleft and flail 123
Asymptomatic Severe Aortic Stenosis and Noncardiac Surgery 122
3D-printing model for complex aortic transcatheter valve treatment 122
Early and mid-term outcomes of 1904 patients undergoing transcatheter balloon-expandable valve implantation in Italy: results from the Italian Transcatheter Balloon-Expandable Valve Implantation Registry (ITER) 122
Diagnostic value and prognostic implications of early cardiac magnetic resonance in survivors of out-of-hospital cardiac arrest 122
Transcatheter aortic valve implantation in patients with severe left ventricular dysfunction: immediate and mid-term results, a multicenter study. 121
Three-Dimensional Electroanatomical Voltage Mapping and Histologic Evaluation of Myocardial Substrate in Right Ventricular Outflow Tract Tachycardia 121
Coronary Flow Reserve by Transthoracic Echocardiography Predicts Epicardial Intimal Thickening in Cardiac Allograft Vasculopathy 120
PCI Versus CABG for Multivessel Coronary Disease in Diabetics 119
Patent foramen ovale closure and migraine time course: Clues for positive interaction 119
Development and validation of a distal embolization risk score during primary angioplasty in ST-elevation myocardial infarction 119
Depressive symptoms, functional measures and long-term outcomes of high-risk ST-elevated myocardial infarction patients treated by primary angioplasty 119
Early and Midterm Clinical and Hemodynamic Outcomes of Transcatheter Valve-in-Valve Implantation: Results From a Multicenter Experience 118
Another passenger for the TAVR speeding train 118
'Full-plastic jacket' with bioresorbable vascular scaffolds: 5-year optical coherence tomography follow-up 117
Typical and atypical Takotsubo syndrome in the same patient. 115
A gender based analysis of predictors of all cause death after transcatheter aortic valve implantation. 115
Apico-Basal Gradient Of Left Ventricular Myocardial Edema Underlies Transient T-Wave Inversion And Qt Interval Prolongation (Wellens' Ecg Pattern) In Tako-Tsubo Cardiomyopathy. 115
Cardiac Magnetic Resonance Features of Biopsy-Proven Endomyocardial Diseases. 115
Contrast induced acute kidney injury in interventional cardiology: An update and key guidance for clinicians 115
At-admission risk stratification for in-hospital life-threatening ventricular arrhythmias and death in non-ST elevation myocardial infarction patients. 114
Impact of Changes in Left Ventricular Ejection Fraction on Survival After Transapical Aortic Valve Implantation 114
Does pre-existing aortic regurgitation protect from death in patients who develop paravalvular leak after TAVI? 114
Safety and effectiveness of a selective strategy for coronary artery revascularization before transcatheter aortic valve implantation. 112
Sirolimus- Versus Paclitaxel-Eluting Stents for the Treatment of Cardiac Allograft Vasculopathy 110
Cardiac rehabilitation after transcatheter versus surgical prosthetic valve implantation for aortic stenosis in the elderly. 110
Low Serum Testosterone as a New Risk Factor for Chronic Rejection in Heart Transplanted Men 110
Early and Midterm Outcome of Propensity-Matched Intermediate-Risk Patients Aged ≥80 Years With Aortic Stenosis Undergoing Surgical or Transcatheter Aortic Valve Replacement (from the Italian Multicenter OBSERVANT Study) 110
Blood oozing: A cause of life-threatening bleeding without overt source after transcatheter aortic valve replacement 110
Incidence, management, and prevention of right ventricular perforation by pacemaker and implantable cardioverter defibrillator leads. 109
Impact of myocardial staining on In-hospital outcome after primary percutaneous coronary intervention in the Padua Registry on ST-elevation myocardial infarction 109
Comparison of balloon-expandable versus self-expandable valves for transcatheter aortic valve implantation in patients with low-gradient severe aortic stenosis and preserved left ventricular ejection fraction 108
Impact of diabetes mellitus on early and midterm outcomes after transcatheter aortic valve implantation (from a multicenter registry). 108
Transaortic balloon-expandable aortic valve implantation. 107
Prognostic value of endocardial voltage mapping in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. 107
Trans-subclavian versus transapical access for transcatheter aortic valve implantation: A multicenter study 107
Myocardial edema underlies dynamic T-wave inversion (Wellens' ECG pattern) in patients with reversible left ventricular dysfunction. 107
Real-World Experience With a Large Bore Vascular Closure Device During TAVI Procedure: Features and Predictors of Access-Site Vascular Complications 107
Atrial fibrillation in patients undergoing transcatheter aortic valve implantation: epidemiology, timing, predictors, and outcome 106
RANKL Expression Is Increased in Circulating Mononuclear Cells of Patients with Calcific Aortic Stenosis 105
Clinical outcome of patients with de novo coronary bifurcation lesions treated with the Tryton Side Branch Stent. The SAFE-TRY prospective multicenter single arm study. 104
Absorb bioresorbable vascular scaffold vs. everolimus-eluting metallic stent in small vessel disease: A propensity matched analysis of COMPARE II, RAI, and MAASSTAD-ABSORB studies 104
Usefulness and Validation of the Survival posT TAVI Score for Survival After Transcatheter Aortic Valve Implantation for Aortic Stenosis. 104
Gender-related differences of diabetic patients undergoing percutaneous coronary intervention with drug-eluting stents: A real-life multicenter experience. 103
Incidence and management of life-threatening arrhythmias in Takotsubo syndrome. 102
The impact of calcium volume and distribution in aortic root injury related to balloon-expandable transcatheter aortic valve replacement 102
Time course of intramyocardial hematoma secondary to Ellis type III coronary rupture during chronic total occlusion intervention 102
Impact of baseline hemorrhagic risk on the benefit of bivalirudin versus unfractionated heparin in patients treated with coronary angioplasty: a meta-regression analysis of randomized trials. 102
Predictors, Incidence, and Outcomes of Patients Undergoing Transfemoral Transcatheter Aortic Valve Implantation Complicated by Stroke 102
Coronary Flow Velocity Reserve by Contrast-Enhanced Transthoracic Echocardiography Predicts Maximal Epicardial Intimal Thickening in Cardiac Allograft Vasculopathy 101
First-in-Human of Catheter-Delivered Annuloplasty Ring to Treat Functional Mitral Regurgitation 101
TAVR with mechanically expandable prostheses: Is balloon aortic valvuloplasty really necessary? 101
Unravelling the (arte)fact of increased pacemaker rate with the Edwards SAPIEN 3 valve. 101
Comparison of impact of mortality risk on the survival benefit of primary percutaneous coronary intervention versus facilitated percutaneous coronary intervention. 100
Everolimus-Eluting Bioresorbable Vascular Scaffold System in the Treatment of Cardiac Allograft Vasculopathy: the CART (Cardiac Allograft Reparative Therapy) Prospective Multicenter Pilot Study 100
Transcatheter repair of combined ascending aortic pseudoaneurysm and aortic arch aneurysm through a cardiac transapical approach 100
Predictors and time-related impact of distal embolization during primary angioplasty 100
Transcatheter Aortic Valve Implantation in Patients With Advanced Chronic Kidney Disease 100
Impact of atrial fibrillation on outcomes of patients treated by transcatheter aortic valve implantation: A systematic review and meta-analysis 100
Percutaneous left atrial appendage occlusion in patients with atrial fibrillation and left appendage thrombus: feasibility, safety and clinical efficacy 100
Comparison between sirolimus- and paclitaxel-eluting stents for the treatment of older patients affected by coronary artery disease: results from a single-center allcomers registry. 99
"in-house" pharmacological management for computed tomography coronary angiography: Heart rate reduction, timing and safety of different drugs used during patient preparation 99
Causes and timing of death during long-term follow-up after transcatheter aortic valve replacement. 98
Myocardial abnormalities underlying persistent ST-segment elevation after anterior myocardial infarction 98
Usefulness of Coronary Sinus Reducer Implantation for the Treatment of Chronic Refractory Angina Pectoris 98
Anatomical and procedural features associated with aortic root rupture during balloon-expandable transcatheter aortic valve replacement. 97
Time-dependent detrimental effects of distal embolization on myocardium and microvasculature during primary percutaneous coronary intervention. 97
One-stage off-pump transapical mitral valve repair and aortic valve replacement. 97
Drug-eluting stents for the treatment of coronary lesions in cardiac transplant vasculopathy: acute and mid-term clinical and angiographic outcomes 96
Transcatheter aortic valve implantation: 3-year outcomes of self-expanding CoreValve prosthesis. 96
Ventricular assist devices. 96
Paclitaxel versus sirolimus eluting stents in diabetic patients: does stent type and/or stent diameter matter? Long-term clinical outcome of 2429-patient multicenter registry. 96
Prognostic value of computed tomography coronary angiography in patients with suspected coronary artery disease: a 24-month follow-up study 96
Potential role of circulating progenitor cells in coronary microvascular dysfunction of heart transplant patients with normal coronary angiograms 95
Asymptomatic right ventricular perforation by an implantable cardioverterdefibrillator lead detected by home monitoring system 95
Chronic kidney disease and percutaneous coronary interventions with drug-eluting stents: Does the K/DOQI classification matter? 95
Interpretation of acute myocardial infarction with persistent 'hyperacute T waves' by cardiac magnetic resonance 95
Management and outcome of spontaneous coronary artery dissection: Conservative therapy versus revascularization 95
Aborted myocardial infarction: a clinical-magnetic resonance correlation 95
Electrocardiographic J waves as a hyperacute sign of Takotsubo syndrome. 95
“Full-plastic jacket” with everolimus-eluting Absorb bioresorbable vascular scaffolds: Clinical outcomes in the multicenter prospective RAI registry (ClinicalTrials.gov Identifier: NCT02298413) 95
Totale 11.194
Categoria #
all - tutte 194.811
article - articoli 190.187
book - libri 412
conference - conferenze 0
curatela - curatele 0
other - altro 160
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.811
Totale 387.381


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.322 0 0 0 0 0 0 0 0 0 618 453 251
2020/20215.283 160 299 416 557 367 353 248 524 728 542 582 507
2021/20227.576 176 819 874 507 323 603 308 814 695 196 599 1.662
2022/20235.372 1.110 537 142 613 772 586 19 331 558 123 256 325
2023/20243.322 146 425 331 252 274 265 255 202 232 134 375 431
2024/20258.417 265 1.047 638 523 1.902 554 669 1.216 1.353 250 0 0
Totale 41.785